Brief: Pharma Equity Announces BOD Decision To Issue Convertible Loans

Pharma Equity A/S

22/01/2024 15:07

Jan 22 (Reuters) - Pharma Equity Group A/S  PEGRP.CO :
    * BOARD OF DIRECTOR'S DECISION TO ISSUE CONVERTIBLE LOANS
    * CONVERTIBLE LOANS ALLOW PHAMA EQUITY GROUP TO BORROW UP TO
DKK
8.914.795
    * LOAN IS GRANTED AS SUBORDINATED LOAN CAPITAL AND IS
THEREFORE
SUBORDINATED TO COMPANY'S OTHER CREDITORS, EXCEPT FOR ANY OTHER
CORRESPONDING SUBORDINATED LOAN CAPITAL
    * LOAN BEARS INTEREST OF 3.25 % PER QUARTER AND REMAINS
WITHOUT
INSTALMENT UNTIL EXPIRY OF EXERCISE PERIOD, AFTER WHICH COMPANY
MUST REPAY LOAN INCLUDING INTEREST WITHIN 60 DAYS, HOWEVER,
COMPANY MAY EXTEND LOAN PERIOD BY 12 MONTHS
    * COMPANY MAY CHOOSE TO PAY LOAN INCLUDING INTEREST IN
SHARES
(CONVERSION OF DEBT INSTRUMENT)
    * MAXIMUM INCREASE OF SHARE CAPITAL PURSUANT TO CONVERTIBLE
LOAN
IS AN AMOUNT OF DKK 12.627.691

Source text for Eikon:  ID:nGNEbncQMt 
Further company coverage:  PEGRP.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))